"STING Pathway Targeted for Antitumor Activity in Lung Adenocarcinoma"

A new study has found that STING, a protein that plays a role in the immune system's response to cancer, can inhibit the reactivation of dormant metastasis in lung adenocarcinoma. Dormant tumor cells can remain inactive for years before reactivating and causing cancer to spread. The study suggests that STING could be a potential target for preventing the reactivation of dormant metastasis and improving cancer treatment outcomes.